The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone - Gierten, J; Ficker, E; Bloehs, R (Naunyn Schmiedebergs Arch Pharmacol, 2010)
et al.